Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma modelPablo Matar, Viviana R Rozados, Silvia I Gervasoni, et al.Clinical & Experimental Metastasis|August 9, 2005
The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretionMaría José Rico, Pablo Matar, Silvia I Gervasoni, et al.Cell Stress & Chaperones|June 25, 2003
Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatinDaniel R Ciocca, Viviana R Rozados, F Darío Cuello Carrión, et al.International Journal of Cancer|July 13, 2002
Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cellsM Mercedes Binda, Pablo Matar, Alejandro D González, et al.Oncology Reports|April 22, 2008
Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor modelsViviana R Rozados, Lucila I Hinrichsen, M Mercedes Binda, et al.Cancer Immunology, Immunotherapy : CII|May 31, 2006
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma modelMariano F Zacarías Fluck, María J Rico, Silvia I Gervasoni, et al.Medicina|January 20, 2012
[Immunomodulation and antiangiogenesis in cancer therapy. From basic to clinical research]O Graciela Scharovsky, Pablo Matar, Viviana R Rozados, et al.Pageof 1